Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
arm has been hurting for almost a year; Pain at injection location; This non-serious case was reported by a consumer and described the occurrence of injection site pain in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included anxiety, depression, blood pressure high, thyroid disorder, allergy and weight. Concomitant products included bupropion hydrochloride (Bupropion), atorvastatin calcium propylene glycol solvate (Atorvastatin), escitalopram oxalate (Escitalopram), hydralazine hydrochloride (Hydralazine), levothyroxine sodium (Levothyroxine), cetirizine hydrochloride (Cetrizine) and semaglutide. On 14-AUG-2024, the patient received Shingrix. On 17-AUG-2024, 3 days after receiving Shingrix, the patient experienced injection site pain (Verbatim: Pain at injection location). On an unknown date, the patient experienced pain in arm (Verbatim: arm has been hurting for almost a year). The outcome of the injection site pain and pain in arm were not resolved. It was unknown if the reporter considered the injection site pain and pain in arm to be related to Shingrix. It was unknown if the company considered the injection site pain and pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 26-JUL-2025 The patient reported that her arm has been hurting for almost a year, more painful when it reaches above her head for a box and at times it almost drops on lifting. It also hurts during the night if the patient lays on the left side. The patient had a constant uncomfortable pain, but more painful in the events stated above. The patient reported that the symptoms was treated.
Allergy; Anxiety; Blood pressure high; Depression; Thyroid disorder; Weight
BUPROPION; ATORVASTATIN; ESCITALOPRAM; HYDRALAZINE; LEVOTHYROXINE; CETRIZINE; SEMAGLUTIDE